GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

GLAXO

Peringkat dalam Saham #3668
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Harga Saham
$27.17
Kapitalisasi Pasar
$4.60B
Perubahan (1 hari)
-1.33%
Perubahan (1 tahun)
-13.30%
Negara
IN
Perdagangan GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Kategori

Healthcare
Riwayat pemecahan saham untuk GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Saham GlaxoSmithKline Pharmaceuticals Limited (simbol: GLAXO) telah mengalami total 1 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Sep 11, 2018.
Satu lembar saham GLAXO yang dibeli sebelum Sep 11, 2018 sekarang setara dengan 2 lembar saham GLAXO.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
2018-09-11 2:1 x2 x2
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
4 x15
US
7 x432
US
0 -
US
7 x226
US
2 x10000
CH